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SUMMARY 
Studies on the evolution of tuberculosis, and the influence of this disease on human and 
animal development and interaction, require the accumulation of indisputable biomarker 
evidence. Ideally, the determination of full genomes would provide all the necessary 
information, but for very old specimens DNA preservation may be compromised and only 
limited DNA amplification may be a possibility. Mycobacterium tuberculosis is characterised 
by the presence of unusual cell envelope lipids, with specific biomarker potential. Lipid 
biomarker recognition has been decisive in pinpointing the oldest known cases of human and 
animal tuberculosis; the former are a woman and child from a pre-pottery settlement at Atlit-
Yam, Israel (~9,000 ka) and the latter is an extinct Bison antiquus from Natural Trap Cave, 
Wyoming (~17,000 ka). Including some new data, it is demonstrated how analysis of a 
combination of mycolic, mycocerosic and mycolipenic acid and phthiocerol biomarkers 
provide incontrovertible evidence for tuberculosis in these landmark specimens. 
 
Keywords: Ancient tuberculosis; Lipids; Biomarkers 
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1. Introduction 
Exploration of the origins and evolution of tuberculosis necessarily relies on the clear 
unambiguous identification of ancient well-characterised archaeological specimens. It would 
be advantageous to identify an extended population of infected individuals but, given the 
likely scarcity of the oldest examples, investigation of single landmark cases may well be a 
productive option. If studies of isolated cases are well-conducted and published in established 
peer-reviewed journals, the results achieved must be properly respected. In this report, the 
incontrovertible evidence for tuberculosis in the oldest human1 and animal2 cases, described 
to date, will be reviewed and some new data included. 
The widest possible combination of complementary methods should be used to diagnose 
ancient mycobacterial disease. For skeletal material, considerable expertise has been 
developed in recognising characteristic bone changes linked to tuberculosis infection.3,4 The 
precise diagnosis of tuberculosis disease requires recognition of decisive biomarkers5 for the 
causative agent Mycobacterium tuberculosis. The amplification of key DNA sequences has 
been systematically developed into widely-applied protocols, during the past two decades 
During the past twenty years, DNA fragment analysis has been extensively utilised.5 Major 
advances in determining full genomic data have been recently provided by the application of 
so-called “Next Generation Sequencing”6 and the more direct “Metagenomic” approach.7  
The predominant feature of the tubercle bacillus is the presence of high proportions of 
long-chain lipids, easily distinguishable from any mammalian lipids. In a pioneering study, 
the 70 to 90 carbon mycolic acids (MAs) (Figure 1A) were clearly identified in a mediaeval 
bone from Addingham, UK, complementing DNA amplification and skeletal indications.8 
The biomarker range has been extended to include multi-methyl-branched mycocerosic and 
mycolipenic acids (Figure 1B).2,9 MAs were originally analysed by fluorescence High 
Performance Liquid Chromatography (HPLC) of slightly unstable methylanthryl esters,8 so a 
special robust derivatisation protocol, involving pyrenebutyrates of pentafluorobenzyl (PFB) 
esters was systematically developed.1,2,9 The mycocerosate and mycolipenate PFB esters can 
be exquisitely detected by Selected Ion Monitoring (SIM) Negative Ion Chemical Ionisation 
(NI-CI) Gas Chromatography Mass Spectrometry.2,9 The value of lipid biomarkers in 
providing decisive confirmation of tuberculosis in key archaeological specimens will be 
reviewed and emphasised. The cases under consideration are Lipid biomarker detection has 
been particularly decisive in diagnosing tuberculosis in ribs from a woman and child from a 
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pre-pottery settlement at Atlit-Yam, Israel (~9,000 ka)1 and an extinct Bison antiquus 
metacarpal from Natural Trap Cave, Wyoming (~17,000 ka).2 However, these clear 
diagnostic data are occasionally overlooked4, so in this communication the data for these two 
landmark cases are presented together and reinforced by some new lipid results. 
2. Landmark studies 
2.1 Nine thousand year old woman and child, Atlit-Yam, Israel 
Archaeological investigations off the coast at Atlit-Yam revealed a submerged coastal 
pre-pottery, post-domestication Neolithic settlement, which included skeletal material from a 
woman and infant with lesions suggestive of tuberculosis.1,10 In particular, the inner aspect of 
the infant cranial bones had serpentine engravings (serpens endocrania symmetrica, SES), 
considered to be diagnostic for intra-thoracic inflammation associated with tuberculosis.1,11 
The tubular bones from the infant, and to a lesser extent from the adult, also demonstrated 
lesions identified as hypertrophic osteoarthropathy (HOA), highly suggestive of 
tuberculosis.1,12 Encouraging results were also achieved for the PCR amplification and 
sequencing of the M. tuberculosis DNA insertion elements IS6110 and IS1081,1 but 
additional confirmation was desirable.  
Carefully crafted robust lipid biomarker studies were found to be ideal complements to 
the above compelling evidence for TB in the Atlit-Yam skeletons.1 The chosen bone samples 
were degraded by a proven alkaline hydrolysis,1,2,8 designed to release the maximum amount 
of mycobacterial lipid biomarkers. Quantitative conversion of the acidic fatty components to 
pentafluorobenzyl (PFB) esters gave lipid biomarkers the ability to be separated reproducibly 
on silica gel cartridges into fractions containing PFB mycolipenate/mycocerosates, PFB 
mycolates and free phthiocerols (Figure 1). The latter two lipid classes were converted to 
stable pyrenebutyric acid (PBA) esters, ideal for sensitive fluorescence HPLC, with the PFB 
mycocerosate/mycolipenates being amenable to NI-CI GC-MS. The assembled lipid 
biomarker profiles for the Atlit-Yam specimens are shown in Figure 2.  
A simple logical sequence is followed for the HPLC characterisation of mycolic acid 
derivatives. The initial “reverse phase” HPLC (Figure 2A) serves to isolate and observe any 
C70 – C90 mycolates free from any smaller mammalian lipids. A “tight envelope” of total 
mycolate peaks, as recorded in Figure 2A, is very characteristic for members of the M. 
tuberculosis complex and, indeed, such clear profiles are immediately very positive 
indications of tuberculosis infections.5,8 The next stage is to subject the collected total 
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mycolates (Figure 2A) to “normal phase” HPLC to separate the α-, methoxy- and 
ketomycolate classes (Figure 1A) according to their polarity (Figure 2B); if clear peaks are 
seen for the individual mycolates, this strengthens the diagnosis of TB. Reverse phase HPLC 
of each of the collected mycolate types (Figure 2B) can provide very diagnostic profiles 
(Figure 2C-E). The α-mycolates are relatively homogeneous, a regular series of C76 to C84 
homologues (Figure 2C) having two cis-cyclopropane rings (Figure 1A). The oxygenated 
mycolates, in contrast, comprise two overlapping homologous series with either cis- or trans-
cyclopropane rings (Figure 1A). A very diagnostic feature of the methoxymycolates from M. 
tuberculosis (Figure 2D) is the presence of a double peak comprising the C87 cis-cyclopropyl 
and C88 trans-cyclopropyl methoxymycolates. Similarly, the ketomycolates from M. 
tuberculosis are characteristically dominated by the presence of the C87 trans-cyclopropyl 
ketomycolate (Figure 2E). This sequential analysis enables a close correlation to be observed 
between the mycolate patterns for the Atlit-Yam specimens and standard M. tuberculosis.  
To support the positive mycolate results, the mycocerosate/mycolipenate (Figure 1B) and 
phthiocerol family (Figure 1C) profiles have been prepared, in unpublished studies, using NI-
CI GC-MS of PFB esters for the former (Figure 2F-I) and fluorescence HPLC of PBA esters 
for the latter (Figure 2J). Again, the mycocerosate/mycolipenate traces (Figure 2F-I) 
correspond well with those for standard M. tuberculosis. Interestingly, the infant showed a 
stronger presence of mycolipenate (Figure 2H, C27 m/z 407). The presence of members of the 
phthiocerol family (Figure 1C) was revealed by reverse phase HPLC (Figure 2J) for ribs from 
the Atlit-Yam Infant and Woman. The main components corresponded to the characteristic 
M. tuberculosis C34 and C36 phthiocerol As (PA) and C33 and C35 phthiodiolones (PO); there 
was insufficient material to carry out confirmatory normal phase HPLC. 
2.2. Seventeen thousand year old bison Natural Trap Cave Wyoming USA 
 Excavations directed by the late Larry D. Martin (1943-2013) of the Biodiversity 
Institute, University of Kansas, in Natural Trap Cave, Wyoming, revealed the presence of a 
variety of well-preserved Pleistocene animal bones2,3. In particular, a metacarpal from a 17 ka 
extinct Bison antiquus showed evidence of lesions “undermining the articular surface”, 
associated with tuberculosis both in humans and animals.2,3 In a landmark study, aDNA 
characteristic of M. tuberculosis rather than M. bovis was clearly identified.12 
A search for lipid biomarkers provided weak but encouraging profiles of mycolic acids 
(Figure 3A-E). Remarkably, absolutely pristine profiles of mycolipenic (C27 m/z 407) and 
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mycocerosic acids (Figure 1B) were recorded for specimens taken both at the lesion (Bison 1) 
and a remote site (Bison 2) (Figure 3F-H). The initial reverse phase HPLC profiles of the 
PBA derivatives of the phthiocerol family fraction (Figure 3I) were not as clean as those for 
the Atlit-Yam skeletons (Figure 2J). Normal phase analysis (Figure 3J) of the collected 
material from the reverse phase separation (Figure 3I) confirmed the presence of members of 
the phthiocerol family, as published previously.2 In addition, to the phthiocerols, however, 
the full normal phase profiles of the PBA derivatives showed the presence of ill-defined 
more-polar components, labelled X, Y and Z in Figure 3J. The presence of these unknown 
components was not reported in the initial study,2 as their identity could not be readily 
understood. One possible explanation is that components X – Z are derived from glycosyl 
phenolphthiocerols, the deacylated so-called “phenolic” glycolipids (PGLs). To investigate 
this hypothesis, the PGL from M. bovis BCG was processed through the hydrolysis and 
extraction protocols and it was found that the resulting PBA derivatives chromatographed in 
a similar fashion to the components X, Y and Z (data not shown). Unfortunately, none of the 
X – Z material remained from the bison samples, so it was not possible to make a precise 
direct comparison. The key conclusion, however, is that the material from Atlit-Yam does not 
show the presence of these potential biomarkers, possibly derived from PGLs (Figure 2J). 
Many modern isolates of M. tuberculosis do not produce PGLs, but they are found in M. 
bovis, M. africanum, certain M. tuberculosis Beijing strains and smooth morphology isolates 
labelled “Mycobacterium canettii”. A recent detailed study13 has confirmed that “M. canettii” 
strains are likely ancient progenitors of modern tuberculosis. The aDNA studies12 ruled out 
M. bovis, but indicated a similarity with M. africanum. Further studies will be needed to 
determine the precise strain of tubercle bacillus infecting the Natural Trap Cave bison. 
3.  Conclusions 
Sound evidence has been assembled, therefore, for the clear diagnosis of tuberculosis in 
~9ka human skeletons and a ~17ka bison metacarpal; these examples provide solid reference 
points for tracing the evolution of tuberculosis back into antiquity. Surprisingly, the actual 
validity of the aDNA results in the properly peer-reviewed Atlit-Yam study2 has been directly 
challenged,14 with no mention being made of the very conclusive MA lipid biomarker 
evidence. Equally, in an otherwise generally comprehensive review on ancient tuberculosis 
and leprosy,4 the critique was repeated but no reference whatsoever was made to a range of 
published lipid biomarker results,5 even though the Atlit-Yam1 and Addingham8 studies were 
cited.4 The inclusion of new mycocerosate/mycolipenate and phthiocerol data for the Atlit-
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
 
Yam specimens (Figure 2F-J) and additional components in the phthiocerol area for the 
Natural Trap Cave bison (Figure 3J) adds further weight to the power of lipid biomarkers in 
the diagnosis of ancient tuberculosis. 
Genomic studies suggest a rapid expansion of modern biotypes of the tubercle bacillus 
following an apparent evolutionary bottleneck at the end of the Pleistocene.13. In a detailed 
examination of the parallel evolution of genomes from 186 members of the M. tuberculosis 
complex and 4,995 human mitochondria, extrapolations were interpreted to suggest that TB 
and humans co-evolved “out of Africa”, commencing ~70 ka ago.15 However, parallel 
evolution is not necessarily linked co-evolution and absolutely no evidence was advanced to 
substantiate the presence of any human tuberculosis going back to 70 ka. Indeed, not a single 
citation was made to any previous publication on the diagnosis of ancient tuberculosis in 
archaeological material! The current lack of any identified cases of Pleistocene TB in Homo 
sapiens and the apparent abundance of the disease in Pleistocene megafauna has led to the 
suggestion that animals may well have been prime vectors to facilitate the emergence of a 
viable tuberculosis pathogen from an environmental ancestor.2 
Dedication:  This paper is dedicated to the memory of Larry Martin (1943 – 2013), formerly 
of the Biodiversity Institute, University of Kansas, whose informed selection of specimens 
from Natural Trap Cave, Wyoming, led directly to the first diagnosis of tuberculosis in 
Pleistocene megafauna. 
Funding: The Leverhulme Trust Project Grant F/00 094/BL (OY-CL, DEM, GSB) 
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Figure legends 
 
Figure 1.  Lipid biomarkers for M. tuberculosis. (A) Generalized structures of α-, methoxy- 
and ketomycolates; the main components are in brackets. (B) Structures of mycolipenate and 
mycocerosates, showing negative carboxylate ions used for selected ion monitoring on NI-CI 
GC-MS analysis of pentafluorobenzyl (PFB) esters. (C) Structures of members of the 
phthiocerol family. 
 
Figure 2.  Mycobacterial lipid profiles from standard M. tuberculosis and Atlit-Yam Woman 
and Infant. (A – E) Reverse and normal phase fluorescence HPLC of mycolate pyrenebutyric 
acid (PBA) derivatives of pentafluorobenzyl (PFB) esters. (F –I) NI-CI GC-MS of 
pentafluorobenzyl (PFB) esters of mycolipenate and mycocerosates; relative intensities are 
shown normalised to the major component [100]. (J) Reverse phase fluorescence HPLC of 
pyrenebutyric acid (PBA) derivatives of members of the phthiocerol family: PA phthiocerol 
A, PB phthiocerol B, PO phthiodiolone. 
 
Figure 3.  Mycobacterial lipid profiles from standard M. tuberculosis and Natural Trap Cave 
Bison metacarpal specimens. (A – E) Reverse and normal phase fluorescence HPLC of 
mycolate pyrenebutyric acid (PBA) derivatives of pentafluorobenzyl (PFB) esters. (F –H) NI-
CI GC-MS of pentafluorobenzyl (PFB) esters of mycolipenate and mycocerosates; relative 
intensities are shown normalised to the major component [100]. (I and H) Reverse (I) and 
normal (J) phase fluorescence HPLC of pyrenebutyric acid (PBA) derivatives of components 
recovered with members of the phthiocerol family: PA phthiocerol A, PB phthiocerol B, PO 
phthiodiolone, X, Y & Z unknown components. 
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